1. A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus

   • Thomas Dörner
   • Edward M. Vital
   • Gerd Burmester

   Review Open access 31 March 2022 Pages: 781 - 802

   

2. Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence

   • Laura C. Coates
   • Maarten de Wit
   • Alexis R. Ogdie

   Review Open access 12 April 2022 Pages: 803 - 821

   

3. Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey

   • Pascal Richette
   • Laura C. Coates
   • Meriem Kessouri

   Original Research Open access 17 March 2022 Pages: 823 - 838

   

4. Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis

   • Roy M. Fleischmann
   • Amy E. Bock
   • Eva Dokoupilová

   Original Research Open access 18 March 2022 Pages: 839 - 850

   

5. An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain

   • Lucy Abraham
   • Kate Halsby
   • Hannah Stevenson

   Original Research Open access 21 March 2022 Pages: 851 - 874

   

6. Analysis of the Pharmacoutilization of Biological Drugs in Psoriatic Arthritis Patients: A Real-World Retrospective Study Among an Italian Population

   • Valentina Perrone
   • Serena Losi
   • Luca Degli Esposti

   Original Research Open access 22 March 2022 Pages: 875 - 890

   

7. Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers

   • Amelia Spinella
   • Marco de Pinto
   • Dilia Giuggioli

   Original Research Open access 25 March 2022 Pages: 891 - 905

   

8. Towards a Better Implementation of Treat-to-Target Strategy in Rheumatoid Arthritis: A Comparison of Two Real-World Cohorts

   • Hong Huang
   • Wenhui Xie
   • Zhuoli Zhang

   Original Research Open access 28 March 2022 Pages: 907 - 917

   

9. Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials

   • Lihi Eder
   • Hans-Peter Tony
   • Alexis Ogdie

   Original Research Open access 09 April 2022 Pages: 919 - 933

   

10. Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications

    • Joseph F. Merola
    • Iain B. McInnes
    • Nehal N. Mehta

    Brief Report Open access 19 March 2022 Pages: 935 - 955